期刊
JOURNAL OF CELLULAR BIOCHEMISTRY
卷 111, 期 6, 页码 1453-1463出版社
WILEY
DOI: 10.1002/jcb.22873
关键词
CHORIONIC PLATE-DERIVED MESENCHYMAL STEM CELLS; HEPATIC FAILURE; TRANSPLANTATION; ANTI-FIBROTIC EFFECT; COLLAGEN SYNTHESIS
资金
- Ministry for Health Welfare & Family Affairs, Republic of Korea [A084633]
- Korea Health Promotion Institute [A084633] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Translational studies have explored the therapeutic effects of stem cells, raising hopes for the treatment of numerous diseases. Here, we evaluated the therapeutic effect of chorionic plate-derived mesenchymal stem cells (CP-MSCs) isolated from human placenta and transplanted into rats with carbon tetrachloride (CCl4)-injured livers. CP-MSCs were analyzed for hepatocyte-specific gene expression, indocyanine green (ICG) uptake, glycogen storage, and urea production following hepatogenic differentiation. PKH26-labeled CP-MSCs were directly transplanted into the livers of rats that had been exposed to CCl4 (1.6g/kg, twice per week for 9 weeks). Blood and liver tissue were analyzed at 1, 2, and 3 weeks post-transplantation. The expression of type I collagen (Col I) and matrix metalloproteinases (MMPs) was analyzed in rat T-HSC/Cl-6 hepatic stellate cells co-cultured with CP-MSCs following exposure to TGF-beta. The expression levels of alpha-smooth muscle actin (alpha-SMA) and Col I were lower in transplanted (TP) rats than in non-transplanted (Non-TP) animals (P<0.05), whereas the expression levels of albumin and MMP-9 were increased. TP rats exhibited significantly higher uptake/excretion of ICG than non-TP rats (P<0.005). In addition, collagen synthesis in T-HSC/Cl-6 cells exposed to TGF-beta was decreased by co-culture with CP-MSCs, which triggered the activation of MMP-2 and MMP-9. These results contribute to our understanding of the potential pathophysiological roles of CP-MSCs, including anti-fibrotic effects in liver disease, and provide a foundation for the development of new cell therapy-based strategies for the treatment of difficult-to-treat liver diseases. J. Cell. Biochem. 111: 1453-1463, 2010. (C) 2010 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据